The Estée Lauder Companies is in the middle of a multi-year operating reset, not a structural decline, and the fiscal 2026 print is the first clean quarter-pair that shows the Profit Recovery and Growth Plan working. Net sales of $15,049 million rose 5 percent on a reported basis and 3 percent in constant currency, the first full year of growth after the 8 percent contraction in fiscal 2025, with fragrance up 12 percent and Mainland China up 12 percent providing the load-bearing contribution. Operating income swung from a $(785) million loss in fiscal 2025 to a $780 million gain in fiscal 2026, although roughly $1,286 million of the swing is the year-over-year reversal of TOM FORD and Too Faced trademark and goodwill impairment charges that were non-recurring in fiscal 2025. Adjusted diluted earnings per share of $2.51 rose 66 percent year-over-year and is the cleaner read on the operating recovery. The principal question is whether the company can convert the gross-margin improvement and the 75.5 percent fiscal 2026 print into a sustained 7 to 8 percent adjusted operating margin in fiscal 2027 once the remaining $935 million of in-flight restructuring charges roll off and the Beauty Reimagined brand investments start paying back.
The central tension is that headline reported earnings still carry a heavy overlay of one-time items, and the analyst's job is to decompose them. Of the $1,565 million year-over-year swing in reported operating income, approximately $1,286 million is the reversal of the fiscal 2025 TOM FORD and Too Faced intangible and goodwill impairments, $84 million is a fiscal 2026 third-quarter securities class action settlement, and $813 million is restructuring and other charges spread across the year versus $481 million in fiscal 2025. Net of all those, the company generated adjusted operating income of $1,687 million, up 47 percent year-over-year, and adjusted gross margin of 75.5 percent is now 150 basis points above the prior year. The shift in mix toward fragrance and Asia travel retail is the structural driver, and the Q4 fiscal 2026 dividend declared at $0.35 per share signals confidence in cash generation.
The latest quarter is fiscal Q4 2026 (year ended June 30, 2026), reported through the annual filing. Reported sales of $3,627 million in Q4 (15,049 minus the $11,422 million nine-month print) were up modestly, gross margin held near 75 percent, and the company's first IEEPA tariff refunds were booked as offsets to cost of sales. Looking forward, the question the next 12 months resolve is whether the Beauty Reimagined strategy and the Profit Recovery and Growth Plan can deliver the targeted $1,200 million of annual gross benefits, the Mainland China growth re-acceleration can hold, and the Tom Ford and Dr.Jart+ trademarks can sustain their fair-value cushion against further cost-of-capital pressure.